Immunotherapy for Food Allergy

3604

Sunday, March 5, 2017: 2:00 PM-3:15 PM

Georgia World Congress Center, Building B, Level 5, Thomas B. Murphy Ballroom 2

Oral Session

1.25 CME/CE

Primary Moderators:

J. Andrew Bird , MD FAAAAI
Lynda C. Schneider , MD FAAAAI

2:00 PM

558

Long-term Walnut Oral Immunotherapy Induces Clinically Relevant Treatment Responses in Tree Nut Allergic Children
Amy M. Scurlock, MD

2:15 PM

559

Sustained Unresponsiveness After Sublingual Immunotherapy for Peanut-allergic Children
Luanna Yang, MD

2:30 PM

560

Adjuvant-Driven Redirection of Th2 Immunity Inhibits Allergic Reactions in Murine Models of Food Allergy
Jessica J. O'Konek, PhD

2:45 PM

561

Increasing Clinical Peanut Thresholds Through Immunotherapy: Quantitative Assessment of the Safety Benefits Associated with Achieving a 300 or 1000 mg Peanut Protein Threshold.
Joseph L Baumert, Ph.D.

3:00 PM

562

Low and High Dose Peanut Oral Immunotherapy (OIT) Similarly Suppress Th2 Cytokine and Basophil Activation Responses
Xiaohong Yue, MS

See more of: Abstracts